Prosight Management, LP Arrowhead Pharmaceuticals, Inc. Transaction History

Prosight Management, LP

  • $372 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$33.21 - $51.27 $3.79 Million - $5.85 Million
-114,100 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$26.12 - $43.27 $244,561 - $405,137
9,363 Added 8.94%
114,100 $4.93 Million
Q1 2020

May 15, 2020
BUY
$20.56 - $63.12 $2.15 Million - $6.61 Million
104,737 New
104,737 $3.01 Million

Others Institutions Holding ARWR

# of Institutions
295
Shares Held
91.1M
Call Options Held
155K
Put Options Held
426K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $1.96B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email